1 / 13

Retinoic Acid Receptor Alpha and Acute Promyelocytic Leukemia

Retinoic Acid Receptor Alpha and Acute Promyelocytic Leukemia. Nidhi Thapar April 1, 2004. Acute Promyelocytic Leukemia. Proliferation of immature blood cells 10,600 new cases of AML each year. Most patients with APL achieve a complete remission when treated (with ATRA).

Download Presentation

Retinoic Acid Receptor Alpha and Acute Promyelocytic Leukemia

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Retinoic Acid Receptor AlphaandAcute Promyelocytic Leukemia Nidhi Thapar April 1, 2004

  2. Acute Promyelocytic Leukemia • Proliferation of immature blood cells • 10,600 new cases of AML each year. • Most patients with APL achieve a complete remission when treated (with ATRA) http://www.cancer.gov http://my.webmd.com/

  3. Retinoic Acid • Member of a family called retinoids, derived from Vitamin A • Enters the nucleus and binds to receptors, initiating transcription factors http://www.ncbi.nlm.nih.gov/

  4. Signalingby Retinoic Acid http://www.ncbi.nlm.nih.gov/

  5. RARα normal function • In the absence of RA RAR/RXR recruits repression complex • Results in transcriptional repression Lin, et al.

  6. RARαnormal function • Presence of RA induces the dissociation of repression complex • Acetylation of histones leads to promoter clearance which activates transcription Lin, et al.

  7. Chromosome Translocation Results in PML • Translocation occurs between chromosomes 15 and 17 • As a result, an abnormal protein product is produced, PML/RARα http://www.genetics.com.au

  8. X- RARα • Leads to differentiation blockage • Activates target genes leading to overexpression

  9. http://www.ncbi.nlm.nih.gov/

  10. Knock-out Mice • RARα-/ RARα- had no effect on phenotype • Triple mutants hard to make http://mbbnet.umn.edu/firsts/mouse.jpeg&imgrefurl

  11. Treatment • High doses of RA in combination with chemotherapy Lin, et al.

  12. HDAC inhibitors • HDAC inhibitors are therapeutic target • Works well in combination with ATRA • Potent inducers of growth arrest, differentiation and apoptosis

  13. thank you

More Related